2SEVENTY BIO INC (TSVT)
US9013841070 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 56.79M | 74.96M | 71.00M | 130.40M | N/A | |||
| Marketable Securities | 124.59M | 142.03M | 195.20M | 134.60M | N/A | |||
| Receivables | 11.98M | 13.41M | 21.00M | 17.00M | 10.70M | |||
| Other Current Assets | 19.48M | 7.37M | 13.70M | 9.50M | 14.40M | |||
| Total Current Assets | 212.84M | 237.76M | 300.90M | 291.60M | 25.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 253.55M | 278.11M | 296.60M | 310.40M | 260.50M | |||
| Investments And Advances | 0.00 | 4.82M | 1.40M | 97.10M | N/A | |||
| Goodwill | N/A | 0.00 | 12.10M | 12.10M | 13.10M | |||
| Intangibles | 6.42M | 6.59M | 7.30M | 9.90M | 5.60M | |||
| Other Non-Current Assets | 38.24M | 38.14M | 38.40M | 38.60M | 8.30M | |||
| Total Non-Current Assets | 298.21M | 327.66M | 355.80M | 468.10M | 287.50M | |||
| TOTAL ASSETS | 511.05M | 565.43M | 656.70M | 759.70M | 312.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 35.27M | 38.35M | 65.80M | 65.20M | 58.70M | |||
| Accounts Payable | 8.80M | 6.03M | 7.20M | 6.00M | 7.20M | |||
| Other Current Liabilities | 16.34M | 15.40M | 6.70M | 27.20M | 10.10M | |||
| Total Current Liabilities | 60.41M | 59.78M | 79.80M | 98.40M | 75.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 243.21M | 250.35M | 266.40M | 301.50M | 162.10M | |||
| Total Non-Current Liabilities | 243.21M | 250.35M | 266.40M | 301.50M | 162.10M | |||
| TOTAL LIABILITIES | 303.61M | 310.13M | 346.20M | 399.90M | 238.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -563.89M | -511.22M | -293.60M | -39.50M | N/A | |||
| Additional Paid In Capital | 771.66M | 766.72M | 607.00M | 400.00M | N/A | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | N/A | |||
| Other Shareholders' Equity | -336.00K | -204.00K | -2.90M | -700.00K | 74.60M | |||
| Shares Outstanding | 51.40M | 50.63M | 37.90M | 23.60M | 23.40M | |||
| Tangible Book Value per Share | 3.91 | 4.91 | 7.68 | 14.31 | 2.39 | |||
| Total Shareholders' Equity | 207.44M | 255.30M | 310.50M | 359.80M | 74.60M | |||
| TOTAL LIABILITIES AND EQUITY | 511.05M | 565.43M | 656.70M | 759.70M | 312.60M | |||
| Statistics | ||||||||
| Current Ratio | 3.52 | 3.98 | 3.77 | 2.96 | 0.33 | |||
| Return On Assets (ROA) | -43.68% | -38.48% | -38.71% | -38.46% | -38.42% | |||
| Return On Equity (ROE) | -107.61% | -85.22% | -81.87% | -81.21% | -160.99% | |||
All data in USD